medigraphic.com

2005, Number 4

<< Back Next >>

Arch Cardiol Mex 2005; 75 (4)

Surgical radiofrequency catheter ablation of accessory pathways in Ebstein’s anomaly

Rivera RL, Iturralde P, Calderón-Colmenero J, Ramírez S, Buendía A

Language: Spanish
References: 12
Page: 421-424
PDF size: 67.66 Kb.


ABSTRACT

Thirteen patients with Ebstein anomaly and atrioventricular reentrant tachycardia and at least one accessory pathway were included in this study. One accessory pathway in 7 (53.8%) patients and multiple accessory pathways in 6 (46.1%) were found. Mahaim accessory pathway was observed in 5 (38.4%) patients. A total of 22 accessory pathways was found, 2 (9%) were concealed. In all (100%), the accessory pathways were located in the tricuspid ring. The most frequent regions were right lateral free wall with 11 (50%) and 5 right posteroseptal (22.7%). Ten patients underwent surgical radiofrequency catheter ablation and three subjected to surgical section. We obtained success in 100%. No complications were observed during the procedures. In conclusion, surgical ablation therapy in patients with accessory pathways and Ebstein’s anomaly is safe and effective.


REFERENCES

  1. Becker AE, Becker MJ, Edwards RJE: Pathologic dysplasia of the tricuspid valve. Arch Path 1971; 91: 167-179.

  2. Muñoz CL, Barros W, García F, Salinas C, Kuri M: Estudio patológico de la displasia y el adosamiento valvular en la anomalía de Ebstein. Arch Inst Cardiol Mex 1993; 63: 101-109.

  3. Mair DD: Ebstein’s anomaly: Natural history and management. JACC 1992; 19: 1047-1048.

  4. Galván O, Iturralde P, Basagoitia AM, De Micheli A: Anomalía de Ebstein con síndrome de Wolff-Parkinson-White. Arch Inst Cardiol Mex 1991; 61: 309-315.

  5. Smith WM, Gallagher JJ, Kerr CR, Seally WC, Kasell JH, Benson DW: The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein’s anomaly of the tricuspid valve. Am J Cardiol 1982; 49: 1223-1234.

  6. Iturralde P, Rivera-Rodríguez L, Guevara-Valdivia M, Colín L, Márquez M, Calvimontes G: Radiofrequency ablation of atrioventricular accessory pathways associated with discordant atrioventricular connections. Cardiol Young 2002; 12: 542-548.

  7. Van Hare GF: Radiofrequency ablation of accessory pathways associated with congenital heart disease. PACE 1997; 20: 2077-2081.

  8. Levine JC, Walsh EP, Saul P: Radiofrequency ablation of accessory pathways associated with congenital heart disease including heterotaxy syndrome. Am J Cardiol 1993; 72: 689-693.

  9. Kocheril AG, Rosenfeld LE: Radiofrequency Ablation of an Accessory Pathway in Patient with Corrected Ebstein’s Anomaly. PACE 1994; 179(1): 986-990.

  10. Cappato R, Schlüter M, Weib C, Antz M, Coschyk DH, Hofmann T, et al: Radiofrequency Current Catheter Ablation of Accessory Pathways in Ebstein’s Anomaly. Circulation 1996; 64: 376-383.

  11. Lara S, Colín L, Iturralde P, Kershenovich S, Ramírez S, González A: Tratamiento no farmacológico de vías accesorias en anomalía de Ebstein. Arch Inst Cardiol Mex 1997; 67: 290-301.

  12. Pressley JC, Wharton JM, Tang AS, Lowe JE, Gallagher J, Prystowsky E: Effect of Ebstein’s anomaly on short and long term outcome of surgically treated patients with Wolff-Parkinson-White syndrome. Circulation 1992; 86: 1147-1155.




2020     |     www.medigraphic.com